UCB0107

DRUG2 trials

Sponsors

UCB Biopharma S.P.R.L.

Conditions

Healthy Japanese VolunteersHealthy Male Volunteers

Phase 1

A Study to Test the Safety, Pharmacokinetics, and Pharmacodynamics of Single Ascending Intravenous Doses of UCB0107 in Healthy Male Subjects

CompletedNCT03464227

UCB Biopharma S.P.R.L.Healthy Male Volunteers

Start: 2018-02-16End: 2018-12-01Updated: 2018-12-12

A Study to Test the Safety and Tolerability and Pharmacokinetics of Single Doses of UCB0107 in Healthy Japanese Subjects

CompletedNCT03605082

UCB Biopharma S.P.R.L.Healthy Japanese Volunteers

Start: 2018-07-25End: 2019-03-11Updated: 2019-03-14

Related Papers

Antibody-based immunotherapies for Parkinsonian syndromes

Neural Regeneration Research2019-01-014 citations